| | | | | |
GOF Guggenheim Strategic Opportunities Fund | $9,6200 | +0,10% | $2,16B | $2,69M | |
CMPR Cimpress PLC Ordinary Shares (Ireland) | $89,3000 | +0,02% | $2,16B | $136,32K | |
PVLA Palvella Therapeutics, Inc. Common Stock | $149,78 | -0,13% | $2,16B | $191,82K | |
| $64,5650 | +0,01% | $2,16B | $253,74K | |
ECPG Encore Capital Group, Inc. | $98,9050 | -0,04% | $2,16B | $363,44K | |
EVT Eaton Vance Tax-Advantaged Dividend Income Fund | $28,8000 | -0,52% | $2,15B | $82,15K | |
NMZ Nuveen Municipal High Income Opportunity Fund | $9,9700 | +0,00% | $2,15B | $610,48K | |
| $26,0550 | -0,02% | $2,14B | $2,05M | |
ESTA Establishment Labs Holdings Inc. | $70,6400 | +0,00% | $2,13B | $285,94K | |
BSTZ BlackRock Science and Technology Term Trust | $31,3500 | +0,19% | $2,13B | $147,36K | |
STC Stewart Information Services Corporation | $69,9100 | +0,00% | $2,13B | $290,92K | |
CTRI Centuri Holdings, Inc. | $20,3200 | +0,00% | $2,13B | $1,28M | |
UA Under Armour, Inc. Class C Common Stock, $0.0003 1/3 par value | $4,9500 | +0,20% | $2,13B | $2,17M | |
HAPN Happen, Inc. Common Stock | $17,8950 | +0,03% | $2,12B | $1,02M | |
ZBIO Zenas BioPharma, Inc. Common Stock | $31,2700 | +0,00% | $2,12B | $439,14K | |
